Cargando…

Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy

PURPOSE: Previous studies have confirmed that neoadjuvant chemoradiotherapy (nCRT) may reduce the number of lymph nodes retrieved in rectal cancer. However, it is still controversial whether it is necessary to harvest at least 12 lymph nodes for locally advanced rectal cancer (LARC) patients who und...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Xing, Jiadi, Zhang, Chenghai, Yao, Zhendan, Wu, Xiuxiu, Jiang, Beihai, Cui, Ming, Su, Xiangqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773987/
https://www.ncbi.nlm.nih.gov/pubmed/36568169
http://dx.doi.org/10.3389/fonc.2022.1080475
_version_ 1784855302703677440
author Yang, Hong
Xing, Jiadi
Zhang, Chenghai
Yao, Zhendan
Wu, Xiuxiu
Jiang, Beihai
Cui, Ming
Su, Xiangqian
author_facet Yang, Hong
Xing, Jiadi
Zhang, Chenghai
Yao, Zhendan
Wu, Xiuxiu
Jiang, Beihai
Cui, Ming
Su, Xiangqian
author_sort Yang, Hong
collection PubMed
description PURPOSE: Previous studies have confirmed that neoadjuvant chemoradiotherapy (nCRT) may reduce the number of lymph nodes retrieved in rectal cancer. However, it is still controversial whether it is necessary to harvest at least 12 lymph nodes for locally advanced rectal cancer (LARC) patients who underwent nCRT regardless of open or laparoscopic surgery. This study was designed to evaluate the relationship between lymph node yield (LNY) and survival in LARC patients who underwent laparoscopic TME following nCRT. METHODS: Patients with LARC who underwent nCRT followed by laparoscopic TME were retrospectively analyzed. The relationship between LNY and survival of patients was evaluated, and the related factors affecting LNY were explored. To further eliminate the influence of imbalance of clinicopathological features on prognosis between groups, propensity score matching was conducted. RESULTS: A total of 257 consecutive patients were included in our study. The median number of LNY was 10 (7 to 13) in the total cohort. There were 98 (38.1%) patients with 12 or more lymph nodes harvested (LNY ≥12 group), and 159 (61.9%) patients with fewer than 12 lymph nodes retrieved (LNY <12 group). There was nearly no significant difference between the two groups in clinicopathologic characteristics and surgical outcomes except that the age of LNY <12 group was older (P<0.001), and LNY <12 group tended to have more TRG 0 cases (P<0.060). However, after matching, when 87 pairs of patients obtained, the clinicopathological features were almost balanced between the two groups. After a median follow-up of 65 (54 to 75) months, the 5-year OS was 83.9% for the LNY ≥12 group and 83.6% for the LNY <12 group (P=0.893), the 5-year DFS was 78.8% and 73.4%, respectively (P=0.621). Multivariate analysis showed that only patient age, TRG score and ypN stage were independent factors affecting the number of LNY (all P<0.05). However, no association was found between LNY and laparoscopic surgery-related factors. CONCLUSIONS: For LARC patients who underwent nCRT followed by laparoscopic TME, the number of LNY less than 12 has not been proved to be an adverse predictor for long-term survival. There was no correlation between LNY and laparoscopic surgery-related factors.
format Online
Article
Text
id pubmed-9773987
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97739872022-12-23 Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy Yang, Hong Xing, Jiadi Zhang, Chenghai Yao, Zhendan Wu, Xiuxiu Jiang, Beihai Cui, Ming Su, Xiangqian Front Oncol Oncology PURPOSE: Previous studies have confirmed that neoadjuvant chemoradiotherapy (nCRT) may reduce the number of lymph nodes retrieved in rectal cancer. However, it is still controversial whether it is necessary to harvest at least 12 lymph nodes for locally advanced rectal cancer (LARC) patients who underwent nCRT regardless of open or laparoscopic surgery. This study was designed to evaluate the relationship between lymph node yield (LNY) and survival in LARC patients who underwent laparoscopic TME following nCRT. METHODS: Patients with LARC who underwent nCRT followed by laparoscopic TME were retrospectively analyzed. The relationship between LNY and survival of patients was evaluated, and the related factors affecting LNY were explored. To further eliminate the influence of imbalance of clinicopathological features on prognosis between groups, propensity score matching was conducted. RESULTS: A total of 257 consecutive patients were included in our study. The median number of LNY was 10 (7 to 13) in the total cohort. There were 98 (38.1%) patients with 12 or more lymph nodes harvested (LNY ≥12 group), and 159 (61.9%) patients with fewer than 12 lymph nodes retrieved (LNY <12 group). There was nearly no significant difference between the two groups in clinicopathologic characteristics and surgical outcomes except that the age of LNY <12 group was older (P<0.001), and LNY <12 group tended to have more TRG 0 cases (P<0.060). However, after matching, when 87 pairs of patients obtained, the clinicopathological features were almost balanced between the two groups. After a median follow-up of 65 (54 to 75) months, the 5-year OS was 83.9% for the LNY ≥12 group and 83.6% for the LNY <12 group (P=0.893), the 5-year DFS was 78.8% and 73.4%, respectively (P=0.621). Multivariate analysis showed that only patient age, TRG score and ypN stage were independent factors affecting the number of LNY (all P<0.05). However, no association was found between LNY and laparoscopic surgery-related factors. CONCLUSIONS: For LARC patients who underwent nCRT followed by laparoscopic TME, the number of LNY less than 12 has not been proved to be an adverse predictor for long-term survival. There was no correlation between LNY and laparoscopic surgery-related factors. Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9773987/ /pubmed/36568169 http://dx.doi.org/10.3389/fonc.2022.1080475 Text en Copyright © 2022 Yang, Xing, Zhang, Yao, Wu, Jiang, Cui and Su https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Hong
Xing, Jiadi
Zhang, Chenghai
Yao, Zhendan
Wu, Xiuxiu
Jiang, Beihai
Cui, Ming
Su, Xiangqian
Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
title Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
title_full Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
title_fullStr Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
title_full_unstemmed Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
title_short Lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic TME following neoadjuvant chemoradiotherapy
title_sort lymph node yield less than 12 is not a poor predictor of survival in locally advanced rectal cancer after laparoscopic tme following neoadjuvant chemoradiotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773987/
https://www.ncbi.nlm.nih.gov/pubmed/36568169
http://dx.doi.org/10.3389/fonc.2022.1080475
work_keys_str_mv AT yanghong lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT xingjiadi lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT zhangchenghai lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT yaozhendan lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT wuxiuxiu lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT jiangbeihai lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT cuiming lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy
AT suxiangqian lymphnodeyieldlessthan12isnotapoorpredictorofsurvivalinlocallyadvancedrectalcancerafterlaparoscopictmefollowingneoadjuvantchemoradiotherapy